Initial Lithium Level Monitoring When Starting Low-Dose Therapy

Lithium Monitoring Guidelines

For standard lithium dosing (targeting therapeutic range of 0.6-1.2 mEq/L), serum lithium concentrations should be checked twice per week during the acute phase until the serum concentrations and clinical condition have stabilized, as recommended by the American Academy of Sleep Medicine 1
The risk of lithium toxicity is directly related to serum lithium concentrations and can occur at doses close to therapeutic concentrations, making monitoring essential but adjustable based on dose, according to the American Academy of Sleep Medicine 2

Concurrent medications, such as NSAIDs and diuretics, that interact with lithium necessitate earlier and more frequent monitoring, as stated by the European Society of Cardiology 3

Failing to establish baseline renal function before initiating lithium therapy is a common mistake, as highlighted by the American Heart Association 4
Overlooking the need for more frequent monitoring if symptoms of toxicity appear, regardless of the scheduled monitoring interval, is a critical error, as warned by the American Academy of Sleep Medicine 2

Renal function should be assessed before starting lithium and monitored regularly, as recommended by the American Journal of Kidney Diseases, to minimize the risk of lithium toxicity in patients with impaired renal function 5
Temporarily suspending lithium during intercurrent illness, planned IV radiocontrast administration, bowel preparation, or prior to major surgery is crucial to prevent lithium toxicity, as suggested by the American Journal of Kidney Diseases 5